DANA-FARBER CANCER INST
Acupuncture for Chemotherapy-induced Peripheral Neuropathy Treatment (ACT)
Acupuncture for Chemotherapy-induced Peripheral Neuropathy Treatment (ACT) is a funding opportunity from DANA-FARBER CANCER INST, up to 659998, closing November 30, 2027.
Nov 30, 2027
(487d left)Overview
R37 extension summary The supplementary study to the R37 ACT trial aims to explore the neurobiological mechanisms behind acupuncture's effectiveness in alleviating chemotherapy-induced peripheral neuropathy (CIPN) pain, focusing on modulating both peripheral and central pain mechanisms. The study has three specific…